Notable Stoke Therapeutics Insider Trades $150K In Company Stock

Comments
Loading...

Huw Nash, COO And Cbo at Stoke Therapeutics STOK, made a large buy and sell of company shares on November 3, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Huw Nash exercised options to purchase 5,700 Stoke Therapeutics shares at a price of $2.19 per share for a total of $12,483 on November 3. They then sold their shares on succeeding transactions in the open market. They sold at prices ranging from $23.41 to $25.00 to raise a total of $136,956 from the stock sale.

Following the transaction, Nash still maintains ownership in the form of derivative securites,totaling 96,322 shares.

Stoke Therapeutics shares are trading down 1.77% at $26.12 at the time of this writing on Thursday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Stoke Therapeutics's Insider Trades.

STOK Logo
STOKStoke Therapeutics Inc
$7.450.68%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum9.60
Growth-
Quality-
Value50.27
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: